Home / Compliance actions / 546956

FDA Warning Letter — Fusion IV Pharmaceuticals, Inc.

Case 546956 — FEI 3013341563

The FDA took a Warning Letter action against Fusion IV Pharmaceuticals, Inc. on Feb 21, 2018 (Los Angeles, CA). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Fusion IV Pharmaceuticals, Inc.
Date
Feb 21, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Los Angeles, CA (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.